Replimune Group, Inc.
REPLNasdaqCIK 1737953HealthcareFiscal year ends Mar 31
Reports and events: 169 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2024-05-1608:14 ET | 10-K | Annual reportPeriod 2024-03-31 | 0001737953-24-000008 |
| 2024-05-1608:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-062296 |
| 2024-03-2607:33 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-038705 |
| 2024-02-0808:09 ET | 10-Q | Quarterly reportPeriod 2023-12-31 | 0001737953-24-000004 |
| 2024-02-0808:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-011951 |
| 2024-01-0808:00 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-002072 |
| 2023-12-2617:15 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation | 0001104659-23-129266 |
| 2023-12-0507:19 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-23-123459 |
| 2023-11-0717:03 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001737953-23-000017 |
| 2023-11-0708:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-23-115027 |
| 2023-09-1908:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-23-101773 |
| 2023-09-0709:17 ET | 8-K | 5.07 Shareholder vote results | 0001104659-23-098814 |
| 2023-08-0309:04 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001104659-23-087083 |
| 2023-08-0308:11 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001737953-23-000013 |
| 2023-08-0308:09 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-23-087059 |
| 2023-07-2617:02 ET | DEF 14A | Proxy statementPeriod 2023-09-06 | 0001104659-23-084367 |
| 2023-07-2008:56 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-23-082566 |
| 2023-06-0508:11 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-23-067856 |
| 2023-05-1808:10 ET | 10-K | Annual reportPeriod 2023-03-31 | 0001737953-23-000009 |
| 2023-05-1808:08 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-23-062103 |
| 2023-02-2708:49 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-23-025680 |
| 2023-02-0908:17 ET | 10-Q | Quarterly reportPeriod 2022-12-31 | 0001737953-23-000005 |
| 2023-02-0908:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-23-014934 |
| 2023-01-0409:15 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-23-000666 |
| 2022-12-1217:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-22-126323 |
| 2022-12-0707:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-22-125054 |
| 2022-12-0617:00 ET | SC 13D/A | Ownership report, active investor, amended | 0001387131-22-012158 |
| 2022-11-0308:13 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001737953-22-000023 |
| 2022-11-0308:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-22-114224 |
| 2022-10-0708:20 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-22-106936 |
| 2022-09-1417:06 ET | SC 13D/A | Ownership report, active investor, amended | 0001387131-22-009795 |
| 2022-09-0816:10 ET | 8-K | 5.07 Shareholder vote results | 0001104659-22-098536 |
| 2022-08-0408:13 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001737953-22-000014 |
| 2022-08-0408:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-22-085894 |
| 2022-07-2708:27 ET | DEF 14A | Proxy statementPeriod 2022-09-07 | 0001104659-22-082980 |
| 2022-06-2316:25 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001104659-22-073917 |
| 2022-06-0308:10 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-22-067870 |
| 2022-05-1908:11 ET | 10-K | Annual reportPeriod 2022-03-31 | 0001737953-22-000010 |
| 2022-05-1908:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-22-062721 |
| 2022-03-3007:28 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-22-039668 |
| 2022-02-0308:18 ET | 10-Q | Quarterly reportPeriod 2021-12-31 | 0001737953-22-000005 |
| 2022-02-0308:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-22-011157 |
| 2022-01-3116:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-22-009561 |
| 2022-01-1008:29 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-22-002526 |
| 2021-12-0209:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-21-145714 |
| 2021-11-0408:14 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001737953-21-000008 |
| 2021-11-0408:13 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-21-134053 |
| 2021-09-0916:16 ET | 8-K | 5.07 Shareholder vote results | 0001104659-21-114198 |
| 2021-08-2516:15 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-21-109335 |
| 2021-08-0608:09 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001737953-21-000003 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 2, 2026, 16:50 ET. Listed shows no prices and gives no investment advice.